<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>MRC Metabolic Diseases Unit</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F2C49356-D1E6-49ED-8E7B-A7D68A4DE4AC"><gtr:id>F2C49356-D1E6-49ED-8E7B-A7D68A4DE4AC</gtr:id><gtr:firstName>Florian</gtr:firstName><gtr:otherNames>Tobias</gtr:otherNames><gtr:surname>Merkle</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FP501967%2F1"><gtr:id>F53B2E6D-5AF6-44E2-AD5C-FC8F3BADDF46</gtr:id><gtr:title>Development of cellular models of hypothalamic disorders</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/P501967/1</gtr:grantReference><gtr:abstractText>Obesity affects over 10 million adults in the UK and is arguably the greatest challenge facing our health care system. Efforts to treat obesity are hampered by the fact that the biological causes of obesity are still poorly understood. Body weight is regulated by a complex network of signals and cell types. A particularly important role is played by specific cell types in the brain that regulate food intake and energy expenditure. It has been known for decades that lesions in a region of the brain known as the hypothalamus can cause extreme obesity or anorexia. More recently, elegant studies in animal models have identified the cell types responsible for feeding behaviour. One of these cell types produces signals known as neuropeptide Y (NPY) and agouti-related peptide (AgRP). These so-called NPY/AgRP neurones so potently stimulate feeding that if they are experimentally killed off in adult mice, the mice completely stop eating. On the other hand, if NPY/AgRP neurones are artificially activated, mice will immediately start eating voraciously. 

Animal models suggest that in models of obesity caused by a high-fat &amp;quot;Western diet&amp;quot;, NPY/AgRP stop responding to the appropriate signals and become abnormally active, thus leading to more food intake and stabilising the state of obesity. It is unclear to what extent human NPY/AgRP are involved in common forms of human obesity. If the pathways that cause these cells to behave abnormally were known, it might possible to correct the abnormalities with targeted drug therapy and generate new therapies for obesity. 

Since cells in the human brain are inaccessible, it has been very difficult to study human NPY/AgRP neurons. I recently developed a method to generate human NPY/AgRP neurons from pluripotent stem cells. These stem cells can be generated by &amp;quot;reprogramming&amp;quot; adult stem cells such as skin cells back to a na&amp;iuml;ve state where they can be directed to produce virtually any other cell type in the body. The ability to generat human NPY/AgRP neurons thus opens up a wide array of new approaches to better understand the cause of obesity. 

As a New Blood MRC fellow, I will study how much NPY and AgRP these neurons release in response to external signals. NPY and AgRP activate other cells to promote feeding, so measuring the release of neuropeptides is a powerful way to understand how they might regulate feeding. In particular, I will study how mutations in genes that have been linked to obesity might affect NPY and AgRP release. These studies will provide an important link between mouse studies and human cells, and may reveal why some people are more prone to obesity than others. A long-term goal of this work is to understand the biological root causes of obesity in order to develop better therapies. I am honoured to be working toward this goal with the support of the MRC.</gtr:abstractText><gtr:technicalSummary>Obesity affects over 10 million adults in the UK and is arguably the greatest challenge facing our health care system. Efforts to treat obesity are hampered by the fact that the mechanisms causing obesity are still poorly understood. A large body of evidence ranging from animal lesion and genetic studies to monogenic and GWAS studies have identified as obesity as largely a disease of the brain. In particular, neurones in the hypothalamus are central regulators of feeding behaviour whose loss or dysfunction is sufficient to cause severe obesity. I have developed a method to generate human hypothalamic neurones from pluripotent stem cells. Human stem cell-derived hypothalamic neurones share cardinal features of their counterparts in the brain. Furthermore, I used the CRISPR/Cas9 system to modify the genomes of human stem cells to generate knock-in reporters for cell types of interest. 

One cell type of particular interest is the hypothalamic neurone that produces neuropeptide Y (NPY) and agouti-related peptide (AgRP). These NPY/AgRP neurones so potently stimulate feeding that their ablation in the adult brain leads to a cessation of feeding to the point of starvation, and their specific activation via pharmacogenetic or optogenetic methods stimulates immediate and voracious feeding. 

As a New Blood MRC fellow, I will develop human stem cell-derived NPY/AgRP neurones into a tractable system for studying obesity. In particular, the secretion of NPY and AgRP peptides from these cells is detectable by ELISA. I will test the hypothesis that candidate obesity-associated mutations in genes that are highly enriched in NPY/AgRP neurones alter neuropeptide release. Since AgRP is a melanocortin peptide that directly inhibits the MC4R receptor found on feeding-inhibitory second order neurones, this phenotype would have a clear mechanistic link to obesity.</gtr:technicalSummary><gtr:fund><gtr:end>2018-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>202833</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Anne White - POMC antibodies and ELISA</gtr:description><gtr:id>E659401C-4676-45B9-BDEE-348E91CA7F3C</gtr:id><gtr:impact>none yet</gtr:impact><gtr:outcomeId>58bede0a3990f6.11038254-1</gtr:outcomeId><gtr:partnerContribution>Prof. White provided proprietary monoclonal antibodies targeting different regions of POMC. Their potency and specificity exceeds that of commercial alternatives. We are using these for immunostaining, Western blotting, and ELISA.</gtr:partnerContribution><gtr:piContribution>We have generated human POMC neurons from stem cells. Our system will enable Prof. White to examine the effect of exogenous factors, such as cortisol, on the expression and processing of POMC prohormone into separate bioactive fragments.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Stem Cell and Regenerative Biology</gtr:department><gtr:description>Collaboration on reporter line generation with Dr. Chad Cowan at Harvard University.</gtr:description><gtr:id>1106B483-1DFD-441D-8A30-EF3DBBC186A0</gtr:id><gtr:impact>There are currently no published outcomes, but a manuscript describing the results is in preparation. The reporter cell line enables us to purify POMC neurons to examine their transcriptome and proteome.</gtr:impact><gtr:outcomeId>5898549f65d392.64418630-1</gtr:outcomeId><gtr:partnerContribution>Dr. Cowan's laboratory has generated and shared with us a knock-in reporter cell line for POMC neurons that inhibit feeding. Unfortunately, attempts at generating an AGRP reporter cell line have to date been unsuccessful, but the the POMC neurons will provide similar insights into feeding regulation, enabling us to carry out the main goals of the proposal. We are now characterising these neurons with the aim of publishing a joint manuscript.</gtr:partnerContribution><gtr:piContribution>As a result of this award, I initiated a collaboration with Dr. Chad Cowan at Harvard University. We shared with Dr. Cowan our hypothalamic differentiation protocol and assays we developed to examine how stem cell-derived neurons respond to exogenous cues.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Cambridge Science Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6BCC462F-C814-4F0A-9DFE-E4F48C9B3410</gtr:id><gtr:impact>I volunteered to serve as a representative of the WT-MRC Institute of Metabolic Science at the Cambridge Science Festival, where hundreds to thousands of members of the public learned about issues in metabolism relating to their daily lives.</gtr:impact><gtr:outcomeId>58987aab84bcc3.90951566</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.sciencefestival.cam.ac.uk/events</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Academy of Medical Sciences Springboard award</gtr:description><gtr:end>2018-08-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:fundingRef>SBF001\1016</gtr:fundingRef><gtr:id>699EFA30-ADC0-4CED-BA23-AB3ED6EAEE66</gtr:id><gtr:outcomeId>58bedf5aa690f2.53501217</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This cell line is a genetic knock-in of GFP at the human POMC locus in an embryonic stem cell line. When differentiated to hypothalamic neurons, it accurately reports on the production of POMC neurons. It was developed in collaboration with Chad Cowan at Harvard University. We are preparing a joint publication describing the work.</gtr:description><gtr:id>8E6AC497-AD55-4443-B9D5-2FA1E37A9A50</gtr:id><gtr:impact>We have been able to flow purify and study the transcriptome of human POMC neurons for the first time.</gtr:impact><gtr:outcomeId>58bee0b0df77d9.94427255</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>POMC-GFP reporter stem cell line</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8698ED29-D8F6-4D06-851B-3B72EA418323</gtr:id><gtr:title>Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec60da3dddaae680a3c7dee1eecb5322"><gtr:id>ec60da3dddaae680a3c7dee1eecb5322</gtr:id><gtr:otherNames>Merkle FT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a34f62df168b3.00375845</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20FC0EF5-75B6-4A2A-91B2-C07376459548</gtr:id><gtr:title>Rapid sensing of L-leucine by human and murine hypothalamic neurons: neurochemical and mechanistic insights</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/555475af5a04080841529f1e873f502a"><gtr:id>555475af5a04080841529f1e873f502a</gtr:id><gtr:otherNames>Heeley N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a902b8cc8f588.70969590</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0691E649-395B-4D91-823A-909F9711C505</gtr:id><gtr:title>Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df5f207ee6289c299594276be9baf960"><gtr:id>df5f207ee6289c299594276be9baf960</gtr:id><gtr:otherNames>Burberry A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>585d7488cf1170.24278118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35FBE253-C2DE-4233-8143-E22B4091CC34</gtr:id><gtr:title>Human POMC processing in vitro and in vivo revealed by quantitative peptidomics</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bbf89e21a215003503baa631ee129c9"><gtr:id>3bbf89e21a215003503baa631ee129c9</gtr:id><gtr:otherNames>Kirwan P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a902b8c872b15.47931660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74CF34B2-371D-4EFA-9919-449A60372A63</gtr:id><gtr:title>Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.</gtr:title><gtr:parentPublicationTitle>Current protocols in stem cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2df2aec79dbfadfbacca70c17f4659f"><gtr:id>f2df2aec79dbfadfbacca70c17f4659f</gtr:id><gtr:otherNames>Santos DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1938-8969</gtr:issn><gtr:outcomeId>58bedcb5971817.22175236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97EF308A-3CE5-47BA-B5B9-2196584E1D8F</gtr:id><gtr:title>Generation and Characterization of Functional Human Hypothalamic Neurons.</gtr:title><gtr:parentPublicationTitle>Current protocols in neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3bbf89e21a215003503baa631ee129c9"><gtr:id>3bbf89e21a215003503baa631ee129c9</gtr:id><gtr:otherNames>Kirwan P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1934-8576</gtr:issn><gtr:outcomeId>5a902c72977692.71287873</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/P501967/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>